Background: Cyclin-dependent kinase inhibitor 1B (p27
SNP), is named for its location 838 base pairs upstream of the translation start site for the p27 gene. The nucleotide for this SNP is a C or an A, and the global minor allele frequency for the A allele is 0.3764 (https://www.ncbi.nlm. nih.gov/snp/?term¼36228499). The AA genotype of the SNP is protective for coronary stents and peripheral vein bypass grafts, in contrast to the AC and CC genotypes, 6, 7 and has been is theorized to produce more p27 protein, and hence, a reduction in cell proliferation. However, the functionality of this SNP has not been determined. Furthermore, a cause-and-effect relationship has not been established between this SNP and the biologic processes underpinning intimal hyperplasia and restenosis. This investigation therefore tested the hypothesis that the p27 SNP is functionally active and differentially modulates the processes that lead to graft failure: cell growth and matrix remodeling.
METHODS
Patient characteristics. Human saphenous vein remnants were obtained from patients undergoing peripheral vascular bypass operations under human studies protocols approved by the University of Washington and the VA Puget Sound Health Care System. All subjects gave informed consent. Paired adventitial cells and SMCs from 35 veins were used for the in vitro experiments described in this report. Characteristics of this group of 35 patients are summarized in the Table. The individual experiments used different subsets of the patient's cell lines (Supplementary Table I , online only). The analysis of cell growth included the clinical characteristics of the patients, in addition to the p27 SNP genotype.
Cell migration from explants and cell culture. After removal of all loose, elastic periadventitial tissue, veins were opened longitudinally. Sections marked intraoperatively with blue dye (toxic to adventitial cells 8 ) and valves were discarded. Endothelium was removed with a cotton-tipped swab. The vein was dissected using a visually and anatomically distinct plane to separate adventitia from the intima/media. To assess the location of the dissection plane, a portion of some veins was fixed in 10% formalin, embedded in paraffin, and sections (4 mm) were stained for smooth muscle a-actin (SMA).
The amount of SMA þ media remaining with the adventitia was determined as a ratio of the thickness of the total intima plus media. Explants of the intima/media and the adventitia (2.5 mm 2 ) were made using a customized McIlwain tissue chopper. Fifteen explants per 25 cm 2 flask were maintained in 1.2 mL 20% fetal bovine serum (FBS)/ Dulbecco's modified Eagles medium (changed thrice weekly). The number of cells (up to a maximum of 100 cells per explant) was counted daily for 8 days.
When cells around the explants became confluent (2-3 weeks), medium was changed to Smooth Muscle Cell Growth Medium (Cell Applications, Inc, San Diego, Calif), which contains 5% FBS and undisclosed amounts of epidermal growth factor, fibroblast growth factor 2, insulin, and heparin (personal communication, James Yu, Cell Applications, Inc). This medium was also used for subsequent growth of passaged cells on collagencoated plastic ware (10 mg/mL bovine skin collagen in phosphate-buffered saline overnight at 4 ). For experiments, matched SMCs and adventitial cells were used at the same passage number, which ranged from 3 to 6 (Supplementary Table I , Online only).
Promoter and deoxyribonuclease I hypersensitivity assays. These assays are described in the Supplementary Methods (online only).
RNA isolation, quantitative real-time polymerase chain reaction, and small interfering RNA treatment. RNA was purified using the Quick-RNA MiniPrep (Plus) kit (Zymo Research, Irvine, Calif). Purity was assessed by the OD260/ 280 ratio (range, 1.85-2.08) and using the Bioanalyzer 2100 (RNA integrity numbers averaged 9.2 6 0.3; Agilent Technologies, Santa Clara, Calif). Knockdown of p27 using small interfering (si)RNA (s2837 Validated Silencer Select; Life Technologies, Inc. Waltham, Mass) was achieved using electroporation (Amaxa Nucleofector Basic Fibroblast kit; Lonza, Basel Switzerland) as described. Cell growth and collagen gel contraction assays. The 3-day cell growth assay in response to 2% FBS plus 10 ng/mL platelet-derived growth factor (PDGF)-BB was performed as described. 8, 9 The cloning experiments are described in the Supplementary Methods (online only). For collagen gel contraction, cells (150,000/mL) were suspended in bovine collagen (1 mg/mL) in serum-free Bovine Basal Smooth Muscle Cell Medium (Cell Applications, Inc) and allowed to polymerize at 37 for 1 hour in a sterile 1-mL plastic syringe. The tip was cut off, and six 0.1-mL plugs were extruded, cut, and individually placed into 35-mm wells. 9 Wells were scanned with transmission illumination and areas quantified using ImageJ software (National Institutes of Health, Bethesda, Md).
Immunocytochemistry. Cells were seeded at 5000/ cm 2 in eight-chamber glass slides coated with bovine type I collagen (10 mg/mL) and grown for 3 days in SMC Western blotting. Cells were extracted in buffer containing 25 mmol/L 4-(2-hydroxyethyl)-1-piperazin eethanesulfonic acid (pH 7.5), 5 mmol/L ethylene diaminetetraacetic acid, 5 mmol/L ethyleneglycote traacetic ethylene glycol tetraacetic acid, 150 mmol/L NaCl, 100 mmol/L Na 4 P 2 O 7 , 50 mmol/L NaF, 1 mmol/L benzamidine, 1% Triton X-100, 10% glycerol, 0.1% bmercaptoethanol, 1 mg/mL pepstatin-A, 5 mg/mL leupeptin, and 5 mg/mL aprotinin.
Equal amounts of protein were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes (BioRad, Richmond, Calif), which were probed with a rabbit anti-p27
Kip1 monoclonal antibody (D69C12; Cell Signaling, Danvers, Mass), followed by peroxidase conjugated antirabbit antibody (KPL, Gaithersburg, Md). Relative protein quantification was performed using chemiluminescence (LumioGLO Reserve; KPL) and scanning films, which were analyzed by ImageJ software using a pooled adventitial cell lysate as an arbitrary control.
Statistics. Paired and unpaired t-tests and two-way analysis of variance analysis were performed as appropriate using SPSS 19 software (IBM, Armonk, NY) or Prism 6 (GraphPad Software, Inc, La Jolla, Calif). Linear regression analysis of the effect of p27 SNP genotype, age, race, diabetes, hypertension, and smoking (current, ever, never) on cell growth was performed with backward elimination of variables from the model (F $ .1 in SPSS 19 software).
RESULTS
Validation and characterization of the vein cells derived from adventitia and intima/media. Microdissection to separate adventitia from intima/media might leave residual medial SMCs within the adventitial specimen. Multiple dissections were analyzed histologically, and the dissection plane was found to generally be through the outer medial layer, an example of which is shown in Supplementary Fig 1 (online only) . We found that the amount of media (delineated by expression of SMA) still attached to the adventitial layer ranged from 0% to 67% of the entire cross-sectional area of media þ intima (41% 6 10%, mean 6 standard error of the mean of six veins), indicating that the separation was imperfect. However, the biologic behavior of the cells derived from these adventitial samples remained consistently different from those from the intimal/media samples. First, the migration of cells from adventitial explants was consistently faster than migration of cells from intimal/ medial explants ( Supplementary Fig 2, A, online only). Second, when a repeated dissection of the adventitia was performed to remove all possible medial cells, we found that migration kinetics of cells from the doubly dissected adventitial explants free of media were the same as the singly dissected adventitial explants containing traces of residual media. The migration kinetics of remnant medial specimens dissected from the adventitia were the same as the primary intimal/medial explants ( Supplementary Fig 2, B) .
To characterize the cells derived from adventitial and intimal/medial tissue, we determined the expression of commonly used markers of SMCs and pericytes. SMCs exhibited greater expression of SMA, caldesmon 1, and neural/glial antigen 2 (a common pericyte marker) compared with adventitial cells (Supplementary Fig 3, online only). There was a trend for higher expression of smooth muscle myosin heavy chain 11 by SMCs, and no difference in the expression of PDGF receptors a and b.
By immunostaining, the percentage of SMA þ adventitial cells was <10%, and >90% of SMCs were positive ( Supplementary Fig 4, A-C, online only). This dichotomous expression of SMA is consistent with the presence of a small number of SMCs in the adventitial cell preparations that may be derived from pericytes or the longitudinal cords of SMCs in adventitia or from the variable amount of residual media on adventitial explants. Finally, because cluster of differentiation (CD) 34 þ progenitor cells in human saphenous vein and pericytes have been reported to have clonogenic properties, 10 we also investigated the clonogenic characteristics of adventitial cells compared with the intimal/medial SMCs. In brief, we found that the clonal potential of the two cell types was the same (Supplementary Table III , online only).
Promoter activity of the A form of the p27 SNP. We previously reported that the A form of a p27 promoter in saphenous vein adventitial cells showed twofold higher activity than the C form of the promoter. 7 We now report the same twofold higher activity in venous SMCs. Fig 1 shows that in both SMCs and adventitial cells, the A form of the p27 promoter was significantly more active.
Identifying transcriptionally active SNPs by deoxyribonuclease I hypersensitivity. The biologic activity of disease-associated noncoding SNPs is thought to be caused by their effect on regulatory DNA elements. 11 To determine whether the p27
Kip1
-838C>A (rs36228499) SNP is located within a regulatory DNA element, we first analyzed rs36228499 in the context of deoxyribonuclease (DNase) I sequencing hypersensitivity data derived from various developmentally diverse human cell types. 12 DNase I hypersensitivity mapping is a powerful tool to delineate regulatory elements within a cell type 13 and demonstrates that rs36228499 is indeed located at the edge of the promoter regulatory element for p27 (Fig 2, A) .
One of the limitations of genetic association studies is that SNPs are often in linkage disequilibrium with multiple other nearby SNPs. Using genetic maps from the 1000 Genomes Project, we identified six other SNPs in linkage disequilibrium with rs36228499 (R 2 > 0.8; Fig 2, B) . Of these SNPs, only the p27 Kip1 -838C>A (rs36228499) SNP and a neighboring SNP rs3759216 were located in DNase I hypersensitive regulatory DNA elements of the cells shown in Fig 2, A. However, of these two SNPs only the p27 Kip1 -838C>A (rs36228499) was present in a DNase I hypersensitive regulatory element in adventitial cells and SMCs (Fig 2, C) . Overall, these data suggest that the p27 Kip1 -838C>A SNP is likely the functional SNP in adventitial cells and in SMCs.
Effect of p27
Kip1 knockdown on cell proliferation and collagen gel contraction. We first performed p27 knockdown experiments to show that p27 could influence relevant biologic processes before testing for an effect of the p27 SNP genotype. For example, p27 is a growth inhibitor via its cyclin-dependent kinase inhibitory domain and can also influence cell contraction via its RhoA and stathmin-binding domains, 14 which regulate the cytoskeleton. Thus, p27 can potentially alter venous cell functions that are relevant to intimal hyperplasia (cell proliferation) or pathological remodeling (cytoskeletal regulation), or both. Collagen gel contraction is a useful model for the study of cytoskeletal function. Therefore, we knocked down p27 mRNA using siRNA and measured cell proliferation and collagen gel contraction, the latter as a model of matrix remodeling. were transfected with the A or C form of the p27 promoter-luciferase constructs. Luciferase activity is expressed as the ratio of A to C construct activity and is the mean of four independent experiments. Data are shown as mean 6 standard error of the mean (error bars). *P < .01, A vs C. Data for the matched adventitial cells was previously published. 5 Knockdown of p27 in adventitial and SMCs with the AA genotype consistently increased growth under a wide variety of growth stimuli (Fig 3, A and B) . Unexpectedly, growth of adventitial cells and SMCs with the CC genotype was not changed after knockdown of p27, suggesting that the AA cells grow under the tonic growth suppression of p27 activity but CC cells do not. Because of differences in knockdown efficiency under the different growth stimuli (Supplementary Table IV , online only), the effect of SNP genotype on cell growth is most clear in basal 2% serum, in which p27 knockdown is >90% in all cells and growth is increased only in AA cells.
Advential Cell
Collagen gel contraction of adventitial cells with the AA genotype was modestly increased after p27 knockdown ( Supplementary Fig 5, online only) . Because this observation validated collagen gel contraction as a biologic process to test for p27 SNP genotype effects, we did not further pursue the effect of p27 knockdown on collagen gel contraction by SMCs or cells with the CC genotype.
Effect of p27 SNP genotype on cell proliferation and collagen gel contraction. Because cell proliferation and collagen gel contraction were altered by p27 knockdown, we tested for responsiveness to the p27 SNP. In PDGF-BB plus 2% serum, adventitial cells of the AA genotype grew significantly more slowly than those with the CC genotype, and the AC cells revealed an intermediate growth rate (Fig 4, A) . Regression analysis showed p27 SNP genotype and age (but not diabetes or hypertension) significantly affected adventitial cell growth (P < .03 and P < .05, respectively; standardized b coefficients are e0.398 and e0.396, respectively). Increased dosage of the A allele and increased age both decreased cell proliferation, but there was a trend for an inhibitory effect of smoking (P ¼ .09; standardized b ¼ e0.306). In contrast, patient characteristics had no significant effects on SMC growth (Fig 4, B) . Because of the small number of female cell lines that were limited to only one genotype, the growth comparisons by genotype were restricted to cells from male cell lines. Those used in cell growth analysis are summarized in Supplementary Table V (online only) .
Although p27 knockdown increased collagen gel contraction, gel contraction did not differ by SNP genotype in adventitial cells or SMCs (Supplementary Fig 6,  online only) . There was also no effect of SNP genotype on serum-mediated collagen gel contraction by adventitial cells (data not presented). Although AA SMCs demonstrated a slightly faster gel contraction than the CC SMCs, this did not reach significance (P ¼ .096) and, overall, the rate of collagen gel contraction was the same by adventitial cells and SMCs.
Effects of p27 SNP genotype on p27 mRNA and p27 protein. The promoter constructs and the DNase I hypersensitivity data indicate that adventitial and SMC cells appear to respond in a similar fashion to differences in this p27 SNP, but only the adventitial cells displayed retarded growth with the AA genotype. We thus measured levels of p27 mRNA and protein using the same growth assay protocol (PDGF-BB plus 2% serum). The adventitial cells and SMCs of the AA genotype both had higher levels of p27 mRNA compared with those with the CC genotype throughout the entire growth time course (Fig 5) . Consistent with this observation, we saw more than twofold higher levels of p27 protein in both cell types with the AA genotype compared with those with the CC genotype at both 0 and 72 hours after addition of PDGF-BB (Fig 6, A and B, respectively; representative Western blots are shown in Supplementary Fig 7, A and B) . Thus, p27 protein reflects p27 message levels and both are higher in cells with the protective AA genotype compared with the CC genotype.
DISCUSSION
This study presents the first conclusive proof that this p27 SNP (p27 Kip1 -838C>A) is indeed functional in venous adventitial cells and in intimal/medial SMCs. First, we found that only p27 Kip1 -838C>A, and not the other SNPs in linkage to it, are in a transcriptionally active site, by using DNase I hypersensitivity assays. 15 Second, in both cell types, the p27 promoter construct with A at the -838 position has more than twofold higher activity than the C promoter construct. Third, levels of p27 mRNA and protein in both cell types are higher in cells with the AA genotype compared with the CC genotype. Finally, knockdown of p27 mRNA increases growth of both cell types with the AA genotype but not those with the CC genotype. This indicates that p27 does not Actions of p27 in adventitial vs SMCs. Although our data indicate that the p27 SNP is functionally active in both cell types (ie, it regulates p27 mRNA and protein), it only retards growth of the adventitial cells (Fig 4) . Coupled with the observation that adventitial cells can contribute to the neointima of vein grafts, 16, 17 these data clearly suggest intimal hyperplasia as a mechanism for graft failure. Supporting this is the observation that the p27 SNP is associated with coronary stent failure, 6 because stent restenosis is largely a result of excessive intimal hyperplasia. However, we previously reported that the p27 SNP is also associated with early remodeling of the vein graft. The AA/AC genotypes show increased graft luminal area 1 month after graft placement, 7 and the luminal area at 1 month is predictive of graft outcome. 3 The modest inhibitory effect of p27 on collagen gel contraction in our p27 knockdown experiments is consistent with the in vivo observation of vein grafts, assuming the A allele increases levels of p27 in vivo. We did not see an effect of p27 SNP genotype on collagen gel contraction, but this may reflect limitations of the gel contraction model, which lacks tension among other relevant factors, as discussed by Kenagy et al. Cell-dependent and tissue-dependent effects on the function of SNPs have been previously described 18 and underscore the context-dependent functionality of SNPs. Cell type-dependent inhibitory or stimulatory effects of p27 knockdown or knockout have been reported previously. For example, inhibitory and stimulatory effects of p27 on migration have been observed, as reviewed by van Tiel et al. 6 The molecular pathways responsible for the regulation of growth responsiveness to the p27 SNP remain to be determined. One possibility is that differences in p27 binding proteins are responsible; for example, p27 binds RhoA, RhoC, and stathmin, 19, 20 which may inhibit p27 activity against other binding partners such as the cyclin-dependent kinases. Alternatively, SMCs may have higher activities of kinases that mediate inhibitory phosphorylation of p27 (eg, Janus kinase 2 on Tyr88
21
). Role of adventitial cells in graft failure. This is the first report to link the biologic behavior of a venous adventitial cell to human vein graft failure. To date, our understanding of the biology of human vein graft failure has been founded on animal models and a small number of human studies, all of which indicate that luminal loss results from a combination of intimal hyperplasia and inadequate positive remodeling. [22] [23] [24] Most research has focused on SMCs as the venous cell responsible for vein graft failure, despite evidence in mouse and rat models for the migration of adventitial cells to the vein graft intima. 16, 17 In these rodent studies, 10% to 30% of intimal cells were derived from the adventitia. It is possible that the adventitia contributes significantly more to the intima in other species; for example, although 40% to 60% of mouse intimal cells are derived from the whole vein graft, which includes any contribution of the adventitia, 25, 26 this figure is 90% for the pig. 27 The contribution of adventitial cells to intimal hyperplasia in human vein grafts is unknown because it cannot be measured with current methods. We have not yet identified the specific cell types that migrate from the venous adventitial explants to become the cultured adventitial cell. From the observation that >90% of adventitial cells do not express SMA, the simplest explanation is that the precursor to the cultured adventitial cell is the CD34 þ adventitial progenitor cell, which does not express SMA in serumcontaining culture medium, whether derived from arteries or saphenous vein. 10, 28 Two other precursor candidates are the SMCs of the adventitial longitudinal cords and pericytes, both of which express SMA under usual serum-containing culture conditions. 28 Another possible source is the endothelial cell, which can undergo endothelial/mesenchymal transition. 29 Supplementary Fig 5 (online only) . The effect of scrambled (Scr) small interfering RNA (siRNA)-mediated knockdown of cyclin-dependent kinase inhibitor 1B (p27 Kip1 ) messenger (m)RNA on collagen gel contraction by adventitial cells. Data are presented as the mean 6 standard error of the mean (error bars) of three experiments performed in duplicate. *P < .05 scr siRNA vs p27 siRNA. Supplementary Fig 6 (online only) . The effect of cyclindependent kinase inhibitor 1B (p27 
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